Purification and characterization of an abnormal factor IX (Christmas factor) molecule. Factor IX Chapel Hill
- PMID: 711853
- PMCID: PMC371868
- DOI: 10.1172/JCI109213
Purification and characterization of an abnormal factor IX (Christmas factor) molecule. Factor IX Chapel Hill
Abstract
Human Factor IX (Christmas factor) was isolated from the plasma of a patient with mild hemophilia B. The patient's plasma contained 5% Factor IX clotting activity but 100% Factor IX antigenic activity as determined by immunological assays, which included inhibitor neutralization and a radioimmunoassay for Factor IX. This abnormal Factor IX is called Factor IX Chapel Hill (Factor IXCH). Both normal Factor IX and Factor IXCH have tyrosine as the NH2-terminal amino acid. The two proteins have a similar molecular weight, a similar amino acid analysis, the same number of gamma-carboxyglutamic acid residues (10 gamma-carboxyglutamic acid residues), and a similar carbohydrate content. Both exist as a single-chain glycoprotein in plasma. The major difference between normal Factor IX and Factor IXCH is that the latter exhibits delayed activation to Factor IXa in the presence of Factor XIa and Ca2+. Thus, Factor IXCH differs from other previously described abnormal Factor IX molecules.
Similar articles
-
The Arg-4 mutant factor IX Strasbourg 2 shows a delayed activation by factor XIa.Nouv Rev Fr Hematol (1978). 1993;35(5):473-80. Nouv Rev Fr Hematol (1978). 1993. PMID: 8295821
-
Characterization of the defect in activation of factor IX Chapel Hill by human factor XIa.J Clin Invest. 1981 Dec;68(6):1420-6. doi: 10.1172/jci110393. J Clin Invest. 1981. PMID: 6976355 Free PMC article.
-
Activation of normal and abnormal human factor IX with trypsin.Arch Biochem Biophys. 1985 May 1;238(2):490-6. doi: 10.1016/0003-9861(85)90192-4. Arch Biochem Biophys. 1985. PMID: 3873217
-
Structure and function of factor IX: defects in haemophilia B.Clin Haematol. 1985 Jun;14(2):359-83. Clin Haematol. 1985. PMID: 3899439 Review.
-
Factor IX of the blood coagulation system: a review.Biochemistry (Mosc). 1997 Jul;62(7):685-93. Biochemistry (Mosc). 1997. PMID: 9331959 Review.
Cited by
-
Immunoaffinity purification of factor IX (Christmas factor) by using conformation-specific antibodies directed against the factor IX-metal complex.Proc Natl Acad Sci U S A. 1985 Jun;82(11):3879-83. doi: 10.1073/pnas.82.11.3879. Proc Natl Acad Sci U S A. 1985. PMID: 2408269 Free PMC article.
-
A candidate activation pathway for coagulation factor VII.Biochem J. 2019 Oct 15;476(19):2909-2926. doi: 10.1042/BCJ20190595. Biochem J. 2019. PMID: 31537632 Free PMC article.
-
Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors.J Clin Invest. 1984 Jun;73(6):1696-703. doi: 10.1172/JCI111377. J Clin Invest. 1984. PMID: 6202716 Free PMC article.
-
Characterization of three abnormal factor IX variants (Bm Lake Elsinore, Long Beach, and Los Angeles) of hemophilia-B. Evidence for defects affecting the latent catalytic site.J Clin Invest. 1985 Jan;75(1):76-83. doi: 10.1172/JCI111700. J Clin Invest. 1985. PMID: 3965513 Free PMC article.
-
Characterization of the clotting activities of structurally different forms of activated factor IX. Enzymatic properties of normal human factor IXa alpha, factor IXa beta, and activated factor IX Chapel Hill.J Clin Invest. 1985 Jan;75(1):4-10. doi: 10.1172/JCI111694. J Clin Invest. 1985. PMID: 3871202 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous